The development of biologics is a complex, high-risk process, often slowed by challenges in protein stability, selectivity, and affinity. Join us for a detailed look into how Schrödinger’s advanced computational protein design platform can help you navigate these hurdles and accelerate your pipeline.

In this exclusive webinar, our experts will provide a technical overview of our unique, physics-based approach to protein engineering and customizable in silico workflow, and discuss several relevant examples. We’ll then dive into a case study, showcasing a recent collaboration where we successfully implemented this rational, structure-based approach to guide the design of a protein cage that assembles stably at neutral pH and disassembles at low pH for controlled payload delivery. By incorporating our computational workflow, the customer was able to dramatically reduce the number of variants tested experimentally, saving valuable time and resources.

Finally, we will provide a clear guide on how to engage with us – from small-scale pilot projects to full-scale collaborations – and show you how our platform can become a powerful extension of your R&D team. Discover how to leverage cutting-edge technology to bring your next biologic to the clinic faster and with a higher probability of success.

Webinar Highlights

• Overview of Schrödinger’s biologics capabilities and offerings for rational antibody design
• Introduction to Schrödinger’s biologics services and how to get started
• Case study: Collaboration in which a structure-based approach successfully guided the design of a pH-controlled protein cage